Search for: "United States v. Abbott Laboratories" Results 121 - 140 of 151
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Feb 2010, 2:52 pm
In Abbott Laboratories v. [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
9 Jan 2009, 7:00 am
Volkswagon-based transfer mandamus order in In re TS Tech USA (Inventive Step) (Hal Wegner) (EDTexweblog.com) (EDTexweblog.com) (Washington State Patent Law Blog) (Patently-O) (Law360) (Patent Prospector) ECJ decides Obelix too famous to be confused with MOBILIX mobile phone service: Les Éditions Albert René Sàrl v Office for Harmonisation in the Internal Market, Orange A/S (Class 46) (IPKat)   Global Global – General Moral… [read post]
15 Mar 2008, 7:00 am
  Shame about the IP: (Afro-IP),Ethiopia receives US trade mark for Sidamo coffee despite opposition from Starbucks: (The IP Factor), (Afro-IP),CC licensed test for African sleeping sickness: (creativecommons.org),Update on PCT applications filed in Nigeria: (Afro-IP),Parallel imports of DVDs to be tested in South Africa: Universal City Studios v Mr Video: (Afro-IP),The W****D C*P of 2*1*: FIFA’s intellectual property rights in South Africa: (Afro-IP),Namibia to adopt… [read post]
27 Dec 2021, 7:02 am by Ana Popovich
One example is the May 10 settlement between the U.S. and the University of Miami (UM), which agreed to pay $22 million to resolve allegations that it “routinely ordered medically unnecessary laboratory tests and used misleading billing practices to increase their reimbursement from Medicare,” a WNN article states. [read post]
26 Nov 2011, 4:46 pm
Abbott LaboratoriesCourt: U.S. 10th Circuit Court of Appeals Docket: 10-4185 November 22, 2011 Judge: Gorsuch Areas of Law: Civil Rights, Labor & Employment Law Plaintiff-Appellant Cherie Lopez-Fisher claimed Defendant-Appellee Abbott Laboratories fired her because of her gender, race, color and national origin. [read post]
25 Jan 2008, 1:00 am
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]Highlights this week included:Chinese company Zhongyi Electronic sues Microsoft for alleged patent infringement relating to technology that converts Roman characters to Chinese characters: (Jurist), (China Hearsay), (IP Dragon),US Patent reform and surrounding controversy: general commentary and opinions: (Patent Baristas), (IPBiz), (IPBiz), (IPBiz), (Patent … [read post]
30 May 2008, 9:09 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WHO members near accord on global strategy on IP and health: (Intellectual Property Watch), (GenericsWeb), (Gowlings), (IAM), Copiepresse seeks up to €49 million from Google in lawsuit over right to feature links to publishers’ content on internet: (IPKat), (Ars Technica), (Techdirt), (Out-Law), (IP Law360) Singapore ‘image… [read post]
13 Feb 2009, 8:00 am
(IPKat)   United States US General Sen Gregg withdraws from nomination to be next Secretary of Commerce (Inventive Step) (Patently-O) Influx of Big Content lawyers at Department of Justice: cause for concern? [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
22 Dec 2011, 11:59 am by Bexis
  All this in a state – Illinois – where the highest court forbids FDCA-based common-law causes of action (see Martin v. [read post]
15 Jul 2019, 5:01 am by Eugene Volokh
The Tenth Circuit has not yet ruled on whether such a First Amendment right of access exists in civil cases, see United States v. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
28 Mar 2008, 6:00 am
: (Patent Docs),US: Alnylam CEO forecasts ‘perfect storm’ for biomedical patents: (Patent Docs),US: Human Genome launches patent suit against Genentech over type of protein used to detect tumours: (IP Law360)Pharma & Biotech - ProductsCaduet (Atorvastatin/Amlodipine) – US: Pfizer sues Ranbaxy to block generic Caduet until 2016: (IP Law360),Dovonex (Calcipotriol) – Chancery Division EWHC grants interim injunction prohibiting Sandoz from distributing… [read post]
21 Nov 2008, 1:36 pm
(IPKat) EU favours disclosure of computer patents before standards are set (Intellectual Property Watch) Trade Marks Court of First Instance finds RAUTARUUKKI fails to satisfy acquired distinctiveness criterion: Rautaruukki Oyj v OHIM (Class 46) Court of First Instance finds original signature of famous Italian lutist Antonio Stradivari, in arte Stradivarius, of the 17th century, cannot be read by relevant consumers: T‑340/06 (Catch Us If You Can!!!) [read post]
25 Jun 2013, 1:27 pm by Rebecca Tushnet
Abbott Laboratories, 201 F.3d 883 (7th Cir. 2000), didn’t apply because the survey wasn’t being used to define the meaning of that phrase. [read post]
30 Aug 2010, 6:20 pm
" United States v. [read post]